endocrinology

Dulaglutide available on PBS for T2D from 1 June

Dulaglutide (Trulicity) will be listed on the PBS from 1 June for the treatment of type 2 diabetes mellitus, the Federal Minister for Health Greg Hunt has announced. The listing of the GLP-1 receptor agonist follows a successful application by Eli Lilly for the 1.5mg once weekly injection to be subsidised for the treatment of ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic